Publications by authors named "T P LaBranche"

Article Synopsis
  • Researchers discovered a potential treatment called BLU-782, a small-molecule inhibitor that selectively targets ALK2, effectively blocking its dysregulated signaling in lab tests.
  • In mouse studies, BLU-782 demonstrated the ability to prevent unwanted bone formation following injury, suggesting it could be a viable preventative treatment for individuals with FOP.
View Article and Find Full Text PDF

Background And Aims: Fibrolamellar carcinoma (FLC) is a rare, difficult-to-treat liver cancer primarily affecting pediatric and adolescent patients, and for which precision medicine approaches have historically not been possible. The gene fusion was identified as a driver of FLC pathogenesis. We aimed to assess whether FLC tumors maintain dependency on this gene fusion and determine if PRKACA is a viable therapeutic target.

View Article and Find Full Text PDF

Background: Upregulation of cAMP-dependent and cAMP-independent PKA signaling is thought to promote cystogenesis in polycystic kidney disease (PKD). PKA-I regulatory subunit RI is increased in kidneys of orthologous mouse models. Kidney-specific knockout of RI upregulates PKA activity, induces cystic disease in wild-type mice, and aggravates it in mice.

View Article and Find Full Text PDF

Fatty liver disease is a potential risk factor for drug-induced liver injury (DILI). Despite advances in nonclinical in vitro and in vivo models to assess liver injury during drug development, the pharmaceutical industry is still plagued by idiosyncratic DILI. Here, we tested the hypothesis that certain features of asymptomatic metabolic syndrome (namely hepatic steatosis) increase the risk for DILI in certain phenotypes of the human population.

View Article and Find Full Text PDF

Glomerulopathy and body weight gain were noted after chronic oral administration of a novel nonsteroidal dissociated agonist of the glucocorticoid receptor compound, fosdagrocorat, to beagle dogs fed an ad libitum diet. To further investigate the role of diet and treatment with either fosdagrocorat or the glucocorticoid comparator, prednisone, on renal safety, a 13-week investigative study was conducted in beagle dogs. Renal histopathology, clinical chemistry, urinalysis, glomerular filtration rate (GFR), body weight, heart rate, blood pressure (BP), and hematology were investigated in restricted- and ad libitum-fed dogs administered prednisone (2.

View Article and Find Full Text PDF